Molecular testing of endometrial carcinoma in real-world clinical practice.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti(2023)

Cited 0|Views8
No score
Abstract
Molecular testing combining immunohistochemical analyses of MMR and p53 proteins in all newly diagnosed EC patients with sequencing analysis of POLE in those with non-low-risk disease is feasible and does not prolong the time needed for treatment decision.
More
Translated text
Key words
endometrial carcinoma,molecular testing,real-world
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined